The implementation and maintenance of the Ketogenic Diet in children

J C Casey1, J McGrogan, D Pillas

  • 1Pediatric Epilepsy Center, Johns Hopkins Medical Institutions, Baltimore, Maryland 21287-7247, USA.

Insights

The Ketogenic Diet effectively treats childhood epilepsy. Successful implementation requires a collaborative approach between families and epilepsy teams, focusing on personalized diet plans and ongoing management for optimal results.

Area of Science:

  • Neurology
  • Pediatrics
  • Nutritional Science

Background:

  • The Ketogenic Diet is a recognized treatment for pediatric epilepsy.
  • Johns Hopkins Hospital has utilized this diet for over 400 children.
  • Effective management necessitates close collaboration between families and specialized epilepsy teams.

Observation:

  • Diet initiation involves comprehensive parent education on the diet's history, mechanism, meal preparation, psychological aspects, complications, and managing co-occurring illnesses.
  • Calculating a ketogenic formula considers standard factors (age, weight, height, activity) alongside secondary medical diagnoses, medications, neurological deficits, feeding challenges, and psychological issues.
  • Ongoing monitoring and adjustments (fine-tuning) are crucial for maximizing antiepileptic effects and supporting healthy growth.

Findings:

  • The Ketogenic Diet demonstrates efficacy in managing pediatric epilepsy.
  • A multidisciplinary approach involving detailed patient assessment and personalized prescription is key.
  • Continuous fine-tuning of the ketogenic diet is essential for sustained therapeutic benefits and patient well-being.

Implications:

  • This dietary therapy offers a viable treatment option for children with epilepsy, potentially reducing seizure frequency and improving quality of life.
  • The findings underscore the importance of individualized treatment plans and robust patient-family support systems in managing complex pediatric conditions.
  • Further research into optimizing ketogenic diet formulations and management strategies can enhance its application in pediatric epilepsy care.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...